Announcement of 2023 Drug Price Revision in Japan The 2023 revision of drug prices in Japan has been announced With 600 drugs being eligible for the price maintenance premium (PMP) and 1,100 drugs eligible for the unprofitable drug reassessment. The PMP will provide an additional 0.1% to 1.0% premium for the first three years of […]